Approved for the treatment of type 2 diabetes and weight management, Semaglutide is marketed under brand names such as Ozempic and Wegovy
They have yet to be studied as a pair, so their safety and effectiveness together is a question mark
The global prevalence of 537 million affected in the age group of 2079 years in 2021 will rise to 783 million in 2045, with the lowest increase in incidence in Europe (13%) and the highest in the African countries south of the Sahara (134%) ( Obesity, defined as a body mass index above 30 kg/m 2 , is also increasingly prevalent worldwide and has become a challenge to the various healthcare systems and societies
depending on coverage and pharmacy
C., Eytan, E., Hershko, A
[2] [3] Understanding the full safety profile of GLP-1 medications, including potential effects on vision, remains essential for both prescribers and patients as use of these agents continues to expand rapidly across diverse patient populations